141 related articles for article (PubMed ID: 28043105)
21. Differential gene expression of transforming growth factors alpha and beta, epidermal growth factor, keratinocyte growth factor, and their receptors in fetal and adult human prostatic tissues and cancer cell lines.
Dahiya R; Lee C; Haughney PC; Chui R; Ho R; Deng G
Urology; 1996 Dec; 48(6):963-70. PubMed ID: 8973690
[TBL] [Abstract][Full Text] [Related]
22. Prostate-specific antigen and 17-hydroxylase polymorphic genotypes in patients with prostate cancer and benign prostatic hyperplasia.
Gunes S; Bagci H; Sarikaya S; Bilen CY; Kara N
DNA Cell Biol; 2007 Dec; 26(12):873-8. PubMed ID: 17961073
[TBL] [Abstract][Full Text] [Related]
23. CCR2 and CCR5 genes polymorphisms in benign prostatic hyperplasia and prostate cancer.
Zambra FM; Biolchi V; Brum IS; Chies JA
Hum Immunol; 2013 Aug; 74(8):1003-8. PubMed ID: 23632061
[TBL] [Abstract][Full Text] [Related]
24. Growth factor, cytokine, and vitamin D receptor polymorphisms and risk of benign prostatic hyperplasia in a community-based cohort of men.
Mullan RJ; Bergstralh EJ; Farmer SA; Jacobson DJ; Hebbring SJ; Cunningham JM; Thibodeau SN; Lieber MM; Jacobsen SJ; Roberts RO
Urology; 2006 Feb; 67(2):300-5. PubMed ID: 16461080
[TBL] [Abstract][Full Text] [Related]
25. Qianliening capsule treats benign prostatic hyperplasia via suppression of the EGF/STAT3 signaling pathway.
Lin J; Zhou J; Xu W; Zhong X; Hong Z; Peng J
Exp Ther Med; 2013 May; 5(5):1293-1300. PubMed ID: 23737867
[TBL] [Abstract][Full Text] [Related]
26. Functional epidermal growth factor gene polymorphisms and risk of gastric cancer.
Zhan Z; Chen Y; Wu J; Zhang J; Tong S; Zhang C; Yang Y
Oncol Lett; 2013 Feb; 5(2):631-636. PubMed ID: 23420566
[TBL] [Abstract][Full Text] [Related]
27. Epidermal growth factor modulates the expression of vascular endothelial growth factor in the human prostate.
Ravindranath N; Wion D; Brachet P; Djakiew D
J Androl; 2001; 22(3):432-43. PubMed ID: 11330643
[TBL] [Abstract][Full Text] [Related]
28. Sex steroids and epidermal growth factor in benign prostatic hyperplasia (BPH).
Sciarra F
Ann N Y Acad Sci; 1995 Jun; 761():66-78. PubMed ID: 7542859
[TBL] [Abstract][Full Text] [Related]
29. Expression of mRNA for epidermal growth factor, transforming growth factor-alpha and their receptor in human prostate tissue and cell lines.
Ching KZ; Ramsey E; Pettigrew N; D'Cunha R; Jason M; Dodd JG
Mol Cell Biochem; 1993 Sep; 126(2):151-8. PubMed ID: 7508078
[TBL] [Abstract][Full Text] [Related]
30. Expression of transforming growth factor-alpha, epidermal growth factor and the epidermal growth factor receptor in adenocarcinoma of the prostate and benign prostatic hyperplasia.
Myers RB; Kudlow JE; Grizzle WE
Mod Pathol; 1993 Nov; 6(6):733-7. PubMed ID: 7508115
[TBL] [Abstract][Full Text] [Related]
31. A study of the functional significance of epidermal growth factor in major depressive disorder.
Tian W; Zhang J; Zhang K; Yang H; Sun Y; Shen Y; Xu Q
Psychiatr Genet; 2012 Aug; 22(4):161-7. PubMed ID: 22504456
[TBL] [Abstract][Full Text] [Related]
32. Prostatic volume and ratio of free-to-total prostate specific antigen in patients with prostatic cancer or benign prostatic hyperplasia.
Haese A; Graefen M; Noldus J; Hammerer P; Huland E; Huland H
J Urol; 1997 Dec; 158(6):2188-92. PubMed ID: 9366341
[TBL] [Abstract][Full Text] [Related]
33. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia.
Ho PJ; Baxter RC
Clin Endocrinol (Oxf); 1997 Mar; 46(3):333-42. PubMed ID: 9156044
[TBL] [Abstract][Full Text] [Related]
34. Relationship between serum prostate-specific antigen and prostate volume in Korean men with benign prostatic hyperplasia: a multicentre study.
Chung BH; Hong SJ; Cho JS; Seong DH
BJU Int; 2006 Apr; 97(4):742-6. PubMed ID: 16536765
[TBL] [Abstract][Full Text] [Related]
35. Comparative analysis of prostatic acid phosphatase and prostate-specific antigen mRNA levels in hyperplastic prostate stimulated with steroid hormones and growth factors.
Dulińska J; Laidler P; Labedź M
Acta Biochim Pol; 2002; 49(2):357-68. PubMed ID: 12362977
[TBL] [Abstract][Full Text] [Related]
36. Molecular Analysis of the SRD5A1 and SRD5A2 Genes in Patients with Benign Prostatic Hyperplasia with Regard to Metabolic Parameters and Selected Hormone Levels.
Rył A; Rotter I; Grzywacz A; Małecka I; Skonieczna-Żydecka K; Grzesiak K; Słojewski M; Szylińska A; Sipak-Szmigiel O; Piasecka M; Walczakiewicz K; Laszczyńska M
Int J Environ Res Public Health; 2017 Oct; 14(11):. PubMed ID: 29084161
[No Abstract] [Full Text] [Related]
37. Immunohistochemical comparative analysis of transforming growth factor alpha, epidermal growth factor, and epidermal growth factor receptor in normal, hyperplastic and neoplastic human prostates.
De Miguel P; Royuela ; Bethencourt R; Ruiz A; Fraile B; Paniagua R
Cytokine; 1999 Sep; 11(9):722-7. PubMed ID: 10479409
[TBL] [Abstract][Full Text] [Related]
38. Relationship between epidermal growth factor and its receptor in human benign prostatic hyperplasia.
Lubrano C; Toscano V; Petrangeli E; Spera G; Trotta MC; Rombolà N; Frati L; Di Silverio F; Sciarra F
J Steroid Biochem Mol Biol; 1993 Oct; 46(4):463-8. PubMed ID: 7692939
[TBL] [Abstract][Full Text] [Related]
39. Possible autocrine loop of the epidermal growth factor system in patients with benign prostatic hyperplasia treated with finasteride: a placebo-controlled randomized study.
Tørring N; Møller-Ernst Jensen K; Lund L; Nielsen JE; Djurhuus JC; Poulsen SS; Nexø E
BJU Int; 2002 Apr; 89(6):583-90. PubMed ID: 11942969
[TBL] [Abstract][Full Text] [Related]
40. Androgenetic alopecia and polymorphism of the androgen receptor gene (SNP rs6152) in patients with benign prostate hyperplasia or prostate cancer.
Kucerova R; Bienova M; Kral M; Bouchal J; Trtkova KS; Burdova A; Student V; Kolar Z
J Eur Acad Dermatol Venereol; 2015 Jan; 29(1):91-6. PubMed ID: 24665929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
